New Zealand's pharmaceutical reference-pricing strategy may backfire

被引：4

|

作者：

Menkes, D

机构：

来源：

LANCET | 2000年 / 355卷 / 9203期

关键词：

D O I：

10.1016/S0140-6736(05)73210-4

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

收藏

页码：558 / 558

页数：1

相关论文

共 50 条

[1] PHARMACEUTICAL COMPANIES PRICING STRATEGIES AFTER GENERIC ENTRY INTO THE NEW ZEALAND MARKET
Rodriguez-Monguio, R.
Seoane-Vazquez, E.
[J]. VALUE IN HEALTH, 2014, 17 (03) : A13 - A14
[2] Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands, and New Zealand
Danzon, Patricia M.
Ketcham, Jonathan D.
[J]. FRONTIERS IN HEALTH POLICY RESEARCH, VOLUME 7, 2004, : 1 - 54
[3] New Zealand's new road safety strategy
Eyre, David
[J]. JOURNAL OF THE AUSTRALASIAN COLLEGE OF ROAD SAFETY, 2010, 21 (02) : 19 - 21
[4] Augmenting reference pricing of pharmaceuticals in New Zealand with strategic cross-product agreements
Woodfield, A
[J]. PHARMACOECONOMICS, 2001, 19 (04) : 365 - 377
[5] The influence of PHARMAC's National Hospital Pharmaceutical Strategy on Quality Use of Medicines activities in New Zealand hospitals
Tordoff, June
Norris, Pauline
Kennedy, Julia
Reith, David
[J]. NEW ZEALAND MEDICAL JOURNAL, 2006, 119 (1239) : 21 - 32
[6] Augmenting Reference Pricing of Pharmaceuticals in New Zealand with Strategic Cross-Product Agreements
Alan Woodfield
[J]. PharmacoEconomics, 2001, 19 : 365 - 377
[7] New Zealand's kiwis may be losing eyesight
Coghlan, Andy
[J]. NEW SCIENTIST, 2017, 235 (3145) : 9 - 9
[8] Pricing Strategy and the Formation and Evolution of Reference Price Perceptions in New Product Categories
Lowe, Ben
Alpert, Frank
[J]. PSYCHOLOGY & MARKETING, 2010, 27 (09) : 846 - 873
[9] New Zealand's hazardous wastes management strategy
Bailey, Margaret L.
NZ
[J]. Clean Air (Melbourne), 1988, 22 (03): : 105 - 108
[10] Change in New Zealand patent law - Some pharmaceutical use claims may now be patentable
不详
[J]. BIOTECHNOLOGY LAW REPORT, 1997, 16 (04): : 463 - 463

← 1 2 3 4 5 →